Collaboration - September 7, 2020
Read the latest issue of our magazine!
Our latest issue, No 03 2020, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges. This issue includes exclusive interviews with scientist and businessman William A. Haseltine and the Chief Scientific Officer of Pfizer Inc, Mikael Dolsten. It also includes a special […]
Collaboration - August 26, 2020
Karolinska Institutet, St. Erik Eye Hospital and Novo Nordisk collaborate
Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generated from embryonic stem cells will be transplanted […]
Collaboration - August 4, 2020
Swedish researchers part of a new IMI consortium
Researchers at Karolinska Institutet are part of a consortium granted almost 66 million euros by the European Innovative Medicines Initiative (IMI) and other parties. The funds will be used to develop, test and facilitate access to chemical substances and other research tools that could pave the way for new drug targets and treatments of diseases […]
Collaboration - June 26, 2020
Zelluna collaborates with Lion TCR
Zelluna Immunotherapy has announced a research collaboration agreement with Lion TCR (Singapore). The collaboration will focus on the development of TCR-NK products for the treatment of virally induced cancers. “This collaboration represents a key milestone for Zelluna and marks an important aspect of our strategy which is to expand our pipeline through in-licensing and partnering,” […]
Collaboration - June 25, 2020
BioVentureHub and Mölnlycke collaborate
AstraZeneca’s BioVentureHub has established a new collaboration with medtech company Mölnlycke to support knowledge exchange across the Swedish life science industry. Small and medium-sized enterprises (SMEs) connected to AstraZeneca’s BioVentureHub will be offered free consultations with Mölnlycke experts with regard to developing products and solutions featuring medical device components. “With increasing focus on precision medicine, […]
Collaboration - June 11, 2020
Orion develops immuno-oncology drug discovery platform
Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO. The national research and innovation project Cancer IO started in May as a part of Business Finland’s Personalized Health Program. The project will develop new solutions to enhance immunotherapy treatments and support the introduction of new therapies. […]
